免疫介导炎症性疾病:从向生物疗法,干细胞疗法转向向细胞疗法
Zhenguo Liang1, Hui Xie2, Dongze Wu3
1Department of Rheumatology and Immunology, The Fifth Affiliated Hospital, Sun Yat-Sen University, Zhuhai, Guangdong, China.
Frontiers in immunology
|April 22, 2025
概括
化学抗原受体T细胞 (CAR-T) 疗法通过耗尽B细胞,对免疫媒介性炎症性疾病 (IMIDs) 显示出有前途的前景,可能会提供超越当前生物治疗的长期缓解.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞疗法细胞疗法
- 炎症性疾病 炎症性疾病
背景情况:
- 免疫媒介炎症疾病 (IMIDs) 的生物疗法在药物维护,反应率和副作用方面面临挑战.
- 干细胞疗法正在成为IMID的潜在救援治疗方法.
- 化学抗原受体T细胞 (CAR-T) 治疗正在研究其在IMID中诱导长期缓解的潜力.
研究的目的:
- 审查目前针对IMID的有针对性的生物疗法的未满足需求.
- 为了比较化学抗原受体T细胞 (CAR-T) 治疗与干细胞移植.
- 评估IMIDsCAR-T治疗的当前状态,潜力和局限性.
主要方法:
- 关于IMIDs的CAR-T治疗的临床前和临床研究的文献综述.
- 对CAR-T疗法和干细胞移植机制的比较分析.
- 对IMID患者的CAR-T治疗疗效和安全现有数据的评估.
主要成果:
- 卡尔-T疗法向并消耗B细胞,为IMID治疗提供了一种新的机制.
- 早期研究表明,CAR-T疗法可能会导致IMID的显著改善和持久缓解.
- 在目标和应用方面,CAR-T疗法和干细胞移植之间存在关键差异.
结论:
- 卡特-T疗法为IMIDs的现有治疗提供了一个有前途的替代方案或补充.
- 需要进一步的研究和临床试验,以确定CAR-T治疗在IMIDs中的作用和优化使用.
- 解决CAR-T疗法的局限性和完善应用对于其成功融入临床实践至关重要.
相关概念视频
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Inflammatory Bowel Disease IV: Pharmacological Management
80
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
80
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
97
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
97
iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
101
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
101


